← Back to Clinical Trials
Recruiting NCT06598878

NCT06598878 AR Gait Training for Parkinson's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06598878
Status Recruiting
Phase
Sponsor Chang Gung University
Condition PD - Parkinson's Disease
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-10-04
Primary Completion 2026-07

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
AR gait training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-10-04 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Gait disorders in Parkinson's disease (PD), particularly in complex environments or under stress, present challenges for accurate evaluation and classification, such as in cases of freezing of gait. Traditional clinical and laboratory settings often fail to replicate the complexity needed for precise classification, making effective rehabilitation difficult. This study aims to address these challenges by developing an augmented reality (AR)-based environment that mimics real-world stressors and dynamically adapts to the patient's condition. The AR system is designed to facilitate individualized gait training and rehabilitation by modifying environmental difficulty based on real-time feedback from gait performance and stress levels. Building on Gentile's taxonomy of tasks, the investigators have incorporated PD-specific factors, such as cognitive dual tasks, into our environment classification system. Preliminary results suggest that this system effectively elicits varying gait and heart rate variability (HRV) responses, indicating different stress levels. This trial will further test the AR environment's ability to classify patients based on their responses to complex, interactive environments, while also investigating the effects of adaptive AR-based gait training on both gait and stress management in individuals with PD.

Eligibility Criteria

Inclusion Criteria: \- Clinical diagnosis of Parkinson disease. Exclusion Criteria: * Musculoskeletal injuries on legs * Osteoporosis. * Any peripheral or central nervous system injury or disease patients.

Frequently Asked Questions

Who can join the NCT06598878 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying PD - Parkinson's Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06598878 currently recruiting?

Yes, NCT06598878 is actively recruiting participants. Visit ClinicalTrials.gov or contact Chang Gung University to inquire about joining.

Where is the NCT06598878 trial being conducted?

This trial is being conducted at Taoyuan, Taiwan.

Who is sponsoring the NCT06598878 clinical trial?

NCT06598878 is sponsored by Chang Gung University. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology